Protein AF-9 (MLLT3) Peptid
MLLT3
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN980124
150,78 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 15 bis 22 Werktagen
Kurzübersicht für Protein AF-9 (MLLT3) Peptid (ABIN980124)
Target
AF9 (MLLT3)
(Protein AF-9 (MLLT3))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-MLLT3 antibody (Catalog #: ARP38489_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- AF9 (MLLT3) (Protein AF-9 (MLLT3))
-
Hintergrund
-
MLLT3 is a regulator of early erythroid and megakaryocytic cell fate in the human system. Expression of MLLT3 in human CD34+ cells induces acute myeloid, lymphoid, or mixed-lineage leukemia in immunodeficient mice. Translocation t (9,11)(p22,q23), a chromosomal aberration involving MLLT3 is associated with acute leukemias.
Alias Symbols: AF9, FLJ2035, YEATS3
Protein Interaction Partner: AFF1,APPBP2,BCOR,C1orf103,C7orf64,CBX8,EEF1A1,MCM6,MLLT3,PTN,APPBP2,BCOR,C1orf103,C7orf64,DOT1L,EEF1A1,MCM6,PTN,SGK1
Protein Size: 568 -
Molekulargewicht
- 63 kDa
-
Gen-ID
- 4300
-
NCBI Accession
- NM_004529, NP_004520
-
UniProt
- P42568
Target
-
Sie sind hier:
